Donald A. Miller
Analyst · Chris Caton with Morgan Stanley
Well, I think, I can break that question down to 2 levels. One, the capital expenditure side, as it relates to leasing capital, obviously, with this sort of pig going through the python for us, I think we're looking at this morning, we had 37% of our lease expirations -- 37% of our portfolio expire in years '11, '12 and '13. A lot of '13 obviously has now been taken care of but -- so we're more than halfway through that. But as you can imagine, the capital side of those tends to lag behind the executional leasing other than for the first half of the commission. And so the capital for the next 2 or 3 years will lag behind the actual execution of the leasing. And so those numbers will be elevated, clearly, over the next 2 or 3 years as we pay the piper, if you will, on all this leasing we've done. Having said that, as you know, we then go into a period of time, '14, '15, '16, where our lease expiration schedule is much, much lower. In fact, de minimis in '15 and '16 at this point. And as a result, we should have a long period of sort of a nice window where we have very low capital expenditures and very low turnover of our portfolio. So that should benefit us. At this point, we have -- because our portfolio is so relatively new, very few of our buildings are much over 12 or 13 years old. There really aren't a lot of major capital projects we have. The only things that we can see going forward, as I mentioned earlier, was 3100 Clarington. We probably have a repositioning of that asset going forward, at some point in time, over the next 3 to 5 years. And then we'll probably have some capital spend on 60 Broad, just because of the age of the asset and some of the systems that we'll have to spend money on going forward. I don't have any specific budgetary numbers to give you on those but those are the only 2 I can think of that have major capital projects ahead of them over the next few years.